• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响光动力疗法治疗日光性角化病全层皮损疼痛强度的因素。

Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses.

机构信息

Department of Dermatology, University Heidelberg, Heidelberg, Germany.

出版信息

J Am Acad Dermatol. 2010 Aug;63(2):213-8. doi: 10.1016/j.jaad.2009.08.062. Epub 2010 Jun 9.

DOI:10.1016/j.jaad.2009.08.062
PMID:20538367
Abstract

BACKGROUND

Topical photodynamic therapy is a good treatment option for extensively photodamaged skin with multiple actinic keratoses. Pain is one of the major adverse effects during and after the treatment.

OBJECTIVE

We sought to determine the pain intensity and its influencing factors during the extensive photodynamic treatment of complete cosmetic units.

METHODS

In total, 104 patients with 411 treated fields were enrolled in this retrospective monocentric study. All patients had multiple actinic keratoses on the face, scalp, or back of hands and received an extensive treatment of the complete photodamaged area in our dermatologic outpatient department between February and May 2009. Pain was rated using a visual analog scale directly and 8 hours after photodynamic therapy.

RESULTS

Multifactorial analysis of the data shows that pain intensity is dependent on sex of the patient (P = .030) and location of the treated field (P < .001). Visual analog scale scores were independent of the age and skin type of the patient. No significant difference in pain between the use of 5-amino-4-oxo-pentanoate (methylaminolevulinate) and 5-aminolevulinic acid was noticed. During treatment, mean visual analog scale scores +/- SEM of the different locations were 2.5 +/- 0.36 (hand), 3.6 +/- 0.35 (occiput), 5.2 +/- 0.19 (forehead), 5.9 +/- 0.20 (cheeks), and 7.4 +/- 0.48 (lips). Eight hours after treatment the mean pain +/- SEM in all locations was reduced significantly (P < .001) from 5.2 +/- 0.14 to 3.0 +/- 0.14. The rate of therapy interruptions showed a significant correlation (P = .044) with the location of the treated field. In all, 71% of the patients showed a good and 29% a poor clinical outcome.

LIMITATIONS

Because of the retrospective study design not all factors that may influence pain (eg, protoporphyrin IX fluorescence) were recorded.

CONCLUSION

These results show that pain intensity is dependent on the location of the treated field. Pain intensity is higher in male patients. After 8 hours pain decreases significantly.

摘要

背景

局部光动力疗法是治疗广泛光损伤皮肤伴多发光化性角化病的有效方法。疼痛是治疗过程中和治疗后主要的不良反应之一。

目的

我们旨在确定在广泛的光动力治疗中治疗完整美容单位时的疼痛强度及其影响因素。

方法

本回顾性单中心研究共纳入 104 例患者的 411 个治疗区。所有患者面部、头皮或手背均有多发光化性角化病,于 2009 年 2 月至 5 月在我院皮肤科门诊接受了广泛的光损伤区域治疗。治疗后直接和 8 小时时使用视觉模拟评分法评估疼痛。

结果

多因素数据分析显示,疼痛强度与患者性别(P =.030)和治疗区部位(P <.001)有关。视觉模拟评分法评分与患者年龄和皮肤类型无关。使用 5-氨基-4-氧代戊酸(甲氨基酮戊酸)和 5-氨基酮戊酸时,疼痛无显著差异。治疗期间,不同部位的平均视觉模拟评分法评分±SEM 分别为 2.5±0.36(手部)、3.6±0.35(枕部)、5.2±0.19(额部)、5.9±0.20(面颊部)和 7.4±0.48(唇部)。治疗 8 小时后,所有部位的平均疼痛±SEM 均显著降低(P <.001),从 5.2±0.14 降至 3.0±0.14。治疗中断率与治疗区部位显著相关(P =.044)。总的来说,71%的患者临床疗效良好,29%的患者临床疗效较差。

局限性

由于本研究为回顾性研究设计,并非所有可能影响疼痛的因素(如原卟啉 IX 荧光)都被记录。

结论

这些结果表明疼痛强度与治疗区部位有关。男性患者疼痛强度更高。治疗 8 小时后疼痛明显减轻。

相似文献

1
Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses.影响光动力疗法治疗日光性角化病全层皮损疼痛强度的因素。
J Am Acad Dermatol. 2010 Aug;63(2):213-8. doi: 10.1016/j.jaad.2009.08.062. Epub 2010 Jun 9.
2
Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.人工白光与日光光动力疗法治疗光化性角化病的随机临床试验。
JAMA Dermatol. 2016 Jun 1;152(6):638-44. doi: 10.1001/jamadermatol.2015.5436.
3
Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis.5-氨基酮戊酸甲酯光动力疗法治疗光化性角化病的疼痛程度低于 5-氨基酮戊酸纳米乳光动力疗法。
Dermatology. 2011;222(4):358-62. doi: 10.1159/000329025. Epub 2011 Jul 12.
4
Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.光动力疗法治疗光化性角化病时使用 5-氨基酮戊酸和红光引起的疼痛:随机对照试验。
Photodermatol Photoimmunol Photomed. 2013 Aug;29(4):173-81. doi: 10.1111/phpp.12044.
5
Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy.光动力疗法治疗光化性角化病时原卟啉IX荧光强度、光漂白、疼痛与临床疗效之间的相关性
Dermatology. 2013;227(3):214-25. doi: 10.1159/000353775. Epub 2013 Oct 15.
6
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.局部皮质类固醇可在不影响光动力疗法治疗光化性角化病疗效的情况下减轻炎症:一项随机临床试验。
Br J Dermatol. 2014 Dec;171(6):1487-92. doi: 10.1111/bjd.13284. Epub 2014 Oct 30.
7
[Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging].[外用氨基乙酰丙酸和红光治疗多发性光化性角化病的回顾性、描述性、观察性研究:临床实践结果及与荧光成像的相关性]
Actas Dermosifiliogr. 2008 Dec;99(10):779-87.
8
Topical photodynamic therapy with porphyrin precursors--assessment of treatment-associated pain in a retrospective study.使用卟啉前体的局部光动力疗法——一项回顾性研究中与治疗相关疼痛的评估
Photochem Photobiol Sci. 2009 Aug;8(8):1111-6. doi: 10.1039/b823378k. Epub 2009 Jun 10.
9
Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.三氯乙酸与外用5-氨基酮戊酸光动力疗法治疗头皮光化性角化病的对比研究
Photodermatol Photoimmunol Photomed. 2015 Sep;31(5):233-8. doi: 10.1111/phpp.12164. Epub 2015 Feb 19.
10
The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.局部氨基酮戊酸光动力疗法治疗面部和头皮中重度光化性角化病的临床疗效。
J Dermatolog Treat. 2010 Jul;21(4):252-7. doi: 10.3109/09546630903271555.

引用本文的文献

1
A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of 10% Aminolevulinic Acid Gel in the Expanded Field-directed Treatment of Actinic Keratosis on the Face and Scalp with Red Light Photodynamic Therapy.一项非随机、开放标签、多中心研究,旨在评估10%氨基乙酰丙酸凝胶联合红光光动力疗法对面部和头皮光化性角化病进行扩大野定向治疗的安全性和耐受性。
J Clin Aesthet Dermatol. 2025 Apr;18(4):44-50.
2
Topical Photodynamic Therapy in a Medical Centre: The Scottish Dermatology Experience.医疗中心的局部光动力疗法:苏格兰皮肤病学经验
Photodermatol Photoimmunol Photomed. 2025 Mar;41(2):e70010. doi: 10.1111/phpp.70010.
3
Exploring Patient Pain Experiences during and after Conventional Red Light and Simulated Daylight Photodynamic Therapy for Actinic Keratosis: A Qualitative Interview Study.
探索光动力疗法治疗光化性角化病期间和之后患者的疼痛体验:一项定性访谈研究。
Acta Derm Venereol. 2024 Apr 10;104:adv19459. doi: 10.2340/actadv.v104.19459.
4
Photodynamic therapy for squamous cell carcinoma of the head and neck: narrative review focusing on photosensitizers.光动力疗法治疗头颈部鳞状细胞癌:以光敏剂为重点的叙述性综述。
Lasers Med Sci. 2022 Apr;37(3):1441-1470. doi: 10.1007/s10103-021-03462-3. Epub 2021 Dec 2.
5
Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.光化性角化病与场癌化治疗的管理要点
Dermatol Ther (Heidelb). 2020 Oct;10(5):903-915. doi: 10.1007/s13555-020-00425-4. Epub 2020 Jul 17.
6
Successful Treatment of Adult-Onset Recurrent Respiratory Papillomatosis with CO Laser and Photodynamic Therapy.二氧化碳激光联合光动力疗法成功治疗成人复发性呼吸道乳头状瘤病
Case Rep Otolaryngol. 2019 Oct 16;2019:7394879. doi: 10.1155/2019/7394879. eCollection 2019.
7
Photosensitization in Porphyrias and Photodynamic Therapy Involves TRPA1 and TRPV1.卟啉症和光动力疗法中的光敏化涉及TRPA1和TRPV1。
J Neurosci. 2016 May 11;36(19):5264-78. doi: 10.1523/JNEUROSCI.4268-15.2016.
8
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.光动力疗法联合治疗非黑色素瘤皮肤癌
Int J Mol Sci. 2015 Oct 28;16(10):25912-33. doi: 10.3390/ijms161025912.
9
Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.光化性角化病皮损的治疗前原卟啉IX浓度可能是基于氨基乙酰丙酸的光动力疗法反应的预测生物标志物。
Photodiagnosis Photodyn Ther. 2015 Dec;12(4):561-6. doi: 10.1016/j.pdpdt.2015.10.006. Epub 2015 Oct 22.
10
Pain reduction in patients after applying a nitrous oxide/oxygen mixture (Livopan) during photodynamic therapy: study protocol for an observational study (Livopan study).光动力疗法期间应用一氧化二氮/氧气混合气体(利沃潘)后患者的疼痛减轻:一项观察性研究的研究方案(利沃潘研究)
BMJ Open. 2015 Mar 30;5(3):e006412. doi: 10.1136/bmjopen-2014-006412.